⌘ Services
mob-logo
Contact Us 800.227.0627
Contact Quote Order Login / Register

News Item

Unlocking the Future of Medicine: The Oligonucleotide Therapeutics Handbook
December 08, 2025
🧬 Unlocking the Future of Medicine: The Oligonucleotide Therapeutics Handbook

The field of medicine is rapidly evolving, with gene-targeting therapies leading the charge. A handbook, authored by Klaus D. Linse, Ph.D., Frank Hong, Ph.D., and Miguel Castro, Ph.D., provides a vital roadmap to this innovative landscape.

The Oligonucleotide Therapeutics Handbook dives deep into the science behind synthetic nucleic acids (ASOs and siRNAs) used to treat complex diseases like cancer, hypercholesterolemia, and neurodegenerative disorders.
Key insights include:

🔬 Mechanisms: From RNase H-mediated degradation to splice-switching and RNA interference (RNAi).

💡 Innovation: Advanced chemical modifications (BNAs/LNAs) and targeted delivery systems (lipid conjugation, nanoparticles).

❗ Impact: Real-world applications and FDA-approved therapies that are changing patient outcomes.

This is essential reading for anyone in the biotech and pharmaceutical sectors looking to stay current on the cutting edge of genetic therapies.
OligonucleotideTherapeutics ASO GeneSilencing Research siRNA DNA Bioconjugation BioSynthesis BSI BioSynthesisInc Oligo

https://lnkd.in/gRzRV3PX

Click here to view the Oligonucleotide Theraputics Handbook

Why Choose Bio-Synthesis

Trusted by biotech leaders worldwide for over 45 years of delivering high-quality, fast, and scalable synthetic biology solutions.

Greetings, Researchers,

Please be advised that any information, guidelines, write-ups, and oral/video/graphic content on our website are intended solely as general guidelines.

It is the researcher's sole responsibility to conduct thorough research on the design of products intended for their experiments before submitting
their designs to Biosynthesis for production feasibility review.

Thank you for your understanding.

Quick Links